Utah Medical Pot Sales Begin
Dragonfly Wellness makes history as the first business to sell cannabis legally in the state.
The marijuana industry is expected to triple in the next five years -- and many investors are looking to profit.
As states and entire countries decriminalize or legalize cannabis and/or its components, there are loads of opportunities for entrepreneurs and existing companies.
But as in any nascent industry, there are also loads of risks and bad actors. Whether you're a first-time investor or a seasoned veteran, it pays to understand all of the moving parts.
This guide will get you up to speed quickly.
Follow these seven steps if you're thinking about buying cannabis stocks. The following is a summary, but we encourage you to read the entire article linked below for all the details.
1. Understand the types of marijuana products.
2. Know the different types of marijuana stocks.
3. Understand the risks of investing in marijuana stocks.
4. Know what to look for in a marijuana stock.
5. Evaluate the top marijuana stocks and exchange-traded funds (ETFs).
6. Invest carefully.
7. Monitor changing industry dynamics closely.
Read more: How to Invest in Marijuana Stocks (Note: includes a list of every major marijuana stock)
We just went step-by-step through how to invest in cannabis, but just because there's a trendy new sector with lots of press and potential growth doesn't mean you need to put your hard-earned money in it. After all, if you buy broad index funds, you're covered no matter what sector of the stock market does well.
Think through the pros and cons as you read on: Should You Invest in Marijuana Stocks?
One of the biggest variables in cannabis investing is to what extent marijuana will be decriminalized or legalized within the United States, both on a state-by-state basis and on a federal basis.
The link below provides a quick spin through what we've seen so far, from decriminalization efforts starting in 1973 to legalization efforts beginning in earnest in 1996 to the political signs of where we seem to be heading.
Read on: Timeline for Marijuana Legalization in the United States: How the Dominoes Are Falling
There's been tremendous interest in Canadian cannabis stocks, because on October 17, 2018, recreational use of marijuana became legal in Canada (it had been legalized on a medical basis since 2001).
Beyond consumption by Canadians, the upside thesis involves operations or distribution to other countries that have legalized or may legalize marijuana to various extents. This includes Germany and particularly the large market on Canada's southern border.
Read on: Everything You Need to Know About Investing in Canadian Marijuana Stocks
One of the difficulties in understanding the marijuana industry is the jargon. Fortunately, it's not too complicated once you get a handle on a few main terms.
Marijuana vs. cannabis
Cannabis is the scientific name of the plant (the genus that houses three species). For an investor's purposes, marijuana is synonymous with cannabis, as are more informal nicknames like pot, weed, ganja, dope, grass, 420, sticky icky, etc.
CBD vs. THC
Cannabis is made up of nearly 500 chemical constituents, including many dozens of cannabinoids (substances that act on the body's cannabinoid receptors).
The two most commercially relevant of these cannabinoids are delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). Only THC is psychoactive (i.e., makes you high).
Hemp
Hemp is a strain of a species of cannabis with relatively low levels of THC and relatively high levels of CBD. It has many industrial uses like providing fibers to make rope and clothing.
Dragonfly Wellness makes history as the first business to sell cannabis legally in the state.
The company also provided an explanation as to why it's delayed reporting.
The company enjoyed tremendous momentum in Q4 compared with the prior-year period. But it continues to spend a lot more than it makes.
The agreement also gives the cannabis producer the ability to export products from Israel to Europe.
The company is buying BlueKudu for an undisclosed sum.
Patients are better off using pharmaceutical CBD than artisanal forms.
It follows in the footsteps of four other African countries that have loosened restrictions on cannabis.
These stocks won't have investors seeing green.
Which of these beaten-down pot stocks is most likely to bounce back?
A Trump re-election could mean little or no progress for cannabis at the federal level.
Is the pure-play pot stock or its big partner the better pick for long-term investors?
While big-time advocates for legalizing marijuana, Sanders and Warren share no love for big businesses.
The measure would limit THC content to 10% for certain patients.
That body must reconcile its version of the bill with the one passed by the State House of Representives this week before sending it to the governor.
CARA earnings call for the period ending December 31, 2019.
If Corbus announces positive results this summer from two late-stage clinical trials, the current stock price could be a steal. But it's not for the faint of heart.
Zogenex's lead drug candidate may soon be approved to treat the same patients targeted by GW Pharmaceutials' Epidiolex.
Analysts have a lot to learn about the still-nascent marijuana industry.
The cannabis company appears to have backed out of its arrangement to buy 420 Investments.
Though the state legalized adult use in 2018, this bill would finally create a functioning system under which marijuana could be sold for non-medical use.